好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Novel Approach for Operationalizing Imaging Import from External Institutions
好色先生, Research, and Methodology
P5 - Poster Session 5 (11:45 AM-12:45 PM)
15-013

We conducted a quality improvement study to improve external imaging access at new patient visits (NPVs). Our goal was to enhance diagnostic workflow, streamline care coordination, and develop a scalable solution.

Timely access to imaging is critical for diagnosis, yet obtaining studies from external institutions remains problematic. This gap causes diagnostic delays, duplicate exams, unnecessary return visits, and added burden on physicians, patients, and staff. Existing solutions, such as EPIC Care Everywhere, provide limited image access, and long-term vendor fixes remain years away. An interim workflow is therefore essential.

Phase 1 consisted of sequential pilots to improve imaging availability at NPVs. Interventions included automated patient text messaging via Penn Medicine's “Switchboard" telecommunications platform, a fake-backend new patient coordinator, and a combined synergistic model. A subsequent pilot tested workflow enhancements such as batching outbound requests. Outcomes included percentage of NPVs with imaging available and time required per patient. In Phase 2, we implemented the pilot-proven synergistic workflow and collected data over a 30-week period. 

At baseline, fewer than 40% of NPVs had external imaging available, with 22% requiring a return visit solely due to missing studies. Phase 1 demonstrated that the text-based intervention improved availability to 48% (n=21), while a resource-focused approach using a fake-backend coordinator reached 80% (n=15). Combining both strategies yielded 88% availability (n=28). Workflow refinements, including batching and enhanced system access, reduced time per patient from 20 to 17 minutes (n=12). Phase 2 captured outcomes over 30 weeks, showing that for n=401, image availability remained high at 85% and time per patient was dramatically reduced to 3.5 minutes. 

Pilot studies demonstrated that a synergistic workflow integrating patient-focused automation with a dedicated resource markedly improved external imaging availability. The workflow yielded sustained improvements in imaging availability. This approach offers a scalable and broadly applicable model to optimize imaging access. 

Authors/Disclosures
Ashna Aggarwal
PRESENTER
Miss Aggarwal has nothing to disclose.
Laura Kavanaugh, MHCI Ms. Kavanaugh has nothing to disclose.
Ivone C. Santos, AA Ms. Santos has nothing to disclose.
Shakyra Gilliard, Sr Administrative Assistant Miss Gilliard has nothing to disclose.
Emma Wilson An immediate family member of Miss Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. An immediate family member of Miss Wilson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/EMD Serono. An immediate family member of Miss Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. An immediate family member of Miss Wilson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. An immediate family member of Miss Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. An immediate family member of Miss Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for William Blair and Company. An immediate family member of Miss Wilson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. An immediate family member of Miss Wilson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. An immediate family member of Miss Wilson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. An immediate family member of Miss Wilson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of an immediate family member of Miss Wilson has received research support from Roche/Genentech.
Margaux Giardino Ms. Giardino has nothing to disclose.
Ashlie Jefferson, MA Ms. Jefferson has nothing to disclose.
Ameena Elahi, MSOD, MPA, RT(R), CIIP Ms. Elahi has nothing to disclose.
Michael Passarella Mr. Passarella has nothing to disclose.
Steve Honeywell, Jr., MBA Mr. Honeywell has stock in Apple and Johnson & Johnson.
Yevgeniy Gitelman, MD Dr. Gitelman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ViyaMD.
Meeseo Lee, BA Miss Lee has nothing to disclose.
Dina Jacobs, MD (Hosp of Univ of PA/Dept of Neruo) Dr. Jacobs has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/EMD Serono. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharmaceuticals. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for William Blair &Company . Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . The institution of Dr. Jacobs has received research support from Roche/Genentech .